Section Arrow
TOVX.NYSE-M
- Theriva Biologics Inc
Quotes are at least 15-min delayed:2026/01/09 19:37 EST
After Hours
Last
 0.2153
+0.0005 (+0.23%)
Bid
0.2145
Ask
0.2154
High 0.2159 
Low 0.2099 
Volume 30.71K 
Regular Hours (Closed)
Last
 0.2148
-0.0046 (-2.10%)
Day High 
0.2218 
Prev. Close
0.2194 
1-M High
0.2603 
Volume 
1.34M 
Bid
0.2145
Ask
0.2154
Day Low
0.2098 
Open
0.218 
1-M Low
0.1651 
Market Cap 
7.83M 
Currency 美元 
P/E 0.11 
%Yield -- 
10-SMA 0.22 
20-SMA 0.21 
50-SMA 0.24 
52-W High 2.03 
52-W Low 0.1651 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
2.06/-2.13
Enterprise Value
8.80M
Balance Sheet
Book Value Per Share
0.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4944+0.11+28.62%-- 
After Hours 0.4907 -0.0037 -0.75%
ASBPAspire Biopharma Holdings Inc.0.104+0.0007+0.68%-- 
After Hours 0.1003 -0.0037 -3.56%
RVMDRevolution Medicines118.64+11.25+10.48%-- 
After Hours 118.5102 -0.1298 -0.11%
ARDXArdelyx7.74+0.74+10.57%-- 
After Hours 7.8156 +0.0756 +0.98%
SLSSELLAS Life Sciences Group3.46-0.4-10.36%-- 
After Hours 3.49 +0.03 +0.87%
Industry overview quotes are at least 15 minutes delayed
Business Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.